Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.

Cuneo A, Mato AR, Rigolin GM, Piciocchi A, Gentile M, Laurenti L, Allan JN, Pagel JM, Brander DM, Hill BT, Winter A, Lamanna N, Tam CS, Jacobs R, Lansigan F, Barr PM, Shadman M, Skarbnik AP, Pu JJ, Sehgal AR, Schuster SJ, Shah NN, Ujjani CS, Roeker L, Orlandi EM, Billio A, Trentin L, Spacek M, Marchetti M, Tedeschi A, Ilariucci F, Gaidano G, Doubek M, Farina L, Molica S, Di Raimondo F, Coscia M, Mauro FR, de la Serna J, Medina Perez A, Ferrarini I, Cimino G, Cavallari M, Cucci R, Vignetti M, Foà R, Ghia P, GIMEMA, European Research Initiative (ERIC) on CLL, US study group

Open source

DOI
10.1002/cam4.3470
Published
2020 Nov
Container
Cancer medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.3470,
  title = {Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.},
  author = {Cuneo A and Mato AR and Rigolin GM and Piciocchi A and Gentile M and Laurenti L and Allan JN and Pagel JM and Brander DM and Hill BT and Winter A and Lamanna N and Tam CS and Jacobs R and Lansigan F and Barr PM and Shadman M and Skarbnik AP and Pu JJ and Sehgal AR and Schuster SJ and Shah NN and Ujjani CS and Roeker L and Orlandi EM and Billio A and Trentin L and Spacek M and Marchetti M and Tedeschi A and Ilariucci F and Gaidano G and Doubek M and Farina L and Molica S and Di Raimondo F and Coscia M and Mauro FR and de la Serna J and Medina Perez A and Ferrarini I and Cimino G and Cavallari M and Cucci R and Vignetti M and Foà R and Ghia P and GIMEMA, European Research Initiative (ERIC) on CLL, US study group},
  year = {2020},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.3470},
  url = {https://doi.org/10.1002/cam4.3470}
}

RIS

TY  - JOUR
TI  - Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.
AU  - Cuneo A
AU  - Mato AR
AU  - Rigolin GM
AU  - Piciocchi A
AU  - Gentile M
AU  - Laurenti L
AU  - Allan JN
AU  - Pagel JM
AU  - Brander DM
AU  - Hill BT
AU  - Winter A
AU  - Lamanna N
AU  - Tam CS
AU  - Jacobs R
AU  - Lansigan F
AU  - Barr PM
AU  - Shadman M
AU  - Skarbnik AP
AU  - Pu JJ
AU  - Sehgal AR
AU  - Schuster SJ
AU  - Shah NN
AU  - Ujjani CS
AU  - Roeker L
AU  - Orlandi EM
AU  - Billio A
AU  - Trentin L
AU  - Spacek M
AU  - Marchetti M
AU  - Tedeschi A
AU  - Ilariucci F
AU  - Gaidano G
AU  - Doubek M
AU  - Farina L
AU  - Molica S
AU  - Di Raimondo F
AU  - Coscia M
AU  - Mauro FR
AU  - de la Serna J
AU  - Medina Perez A
AU  - Ferrarini I
AU  - Cimino G
AU  - Cavallari M
AU  - Cucci R
AU  - Vignetti M
AU  - Foà R
AU  - Ghia P
AU  - GIMEMA, European Research Initiative (ERIC) on CLL, US study group
PY  - 2020
JO  - Cancer medicine
DO  - 10.1002/cam4.3470
UR  - https://doi.org/10.1002/cam4.3470
ER  -

APA

A, C., AR, M., GM, R., A, P., M, G., L, L., JN, A., JM, P., DM, B., BT, H., A, W., N, L., CS, T., R, J., F, L., PM, B., M, S., AP, S., JJ, P., AR, S., SJ, S., NN, S., CS, U., L, R., EM, O., A, B., L, T., M, S., M, M., A, T., F, I., G, G., M, D., L, F., S, M., F, D. R., M, C., FR, M., J, D. L. S., A, M. P., I, F., G, C., M, C., R, C., M, V., R, F., P, G., & group, G. E. R. I. (. O. C. U. S. (2020). Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.. Cancer medicine. https://doi.org/10.1002/cam4.3470

Source records